367 related articles for article (PubMed ID: 36481435)
21. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
22. α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.
Stuendl A; Kraus T; Chatterjee M; Zapke B; Sadowski B; Moebius W; Hobert MA; Deuschle C; Brockmann K; Maetzler W; Mollenhauer B; Schneider A
Mov Disord; 2021 Nov; 36(11):2508-2518. PubMed ID: 34002893
[TBL] [Abstract][Full Text] [Related]
23. Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.
Lin CH; Yang SY; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH; Chiu MJ
Front Aging Neurosci; 2018; 10():123. PubMed ID: 29755341
[No Abstract] [Full Text] [Related]
24. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
[TBL] [Abstract][Full Text] [Related]
25. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
Agliardi C; Meloni M; Guerini FR; Zanzottera M; Bolognesi E; Baglio F; Clerici M
Neurobiol Dis; 2021 Jan; 148():105185. PubMed ID: 33217562
[TBL] [Abstract][Full Text] [Related]
26. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies.
Vacchi E; Lazzarini E; Pinton S; Chiaro G; Disanto G; Marchi F; Robert T; Staedler C; Galati S; Gobbi C; Barile L; Kaelin-Lang A; Melli G
Brain; 2022 Aug; 145(8):2755-2768. PubMed ID: 35485527
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
[TBL] [Abstract][Full Text] [Related]
28. Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.
Jiang C; Hopfner F; Katsikoudi A; Hein R; Catli C; Evetts S; Huang Y; Wang H; Ryder JW; Kuhlenbaeumer G; Deuschl G; Padovani A; Berg D; Borroni B; Hu MT; Davis JJ; Tofaris GK
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):720-729. PubMed ID: 32273329
[TBL] [Abstract][Full Text] [Related]
29. The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders.
Rittman T; Ghosh BC; McColgan P; Breen DP; Evans J; Williams-Gray CH; Barker RA; Rowe JB
J Neurol Neurosurg Psychiatry; 2013 May; 84(5):544-51. PubMed ID: 23303961
[TBL] [Abstract][Full Text] [Related]
30. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again.
Compta Y; Painous C; Soto M; Pulido-Salgado M; Fernández M; Camara A; Sánchez V; Bargalló N; Caballol N; Pont-Sunyer C; Buongiorno M; Martin N; Basora M; Tio M; Giraldo DM; Pérez-Soriano A; Zaro I; Muñoz E; Martí MJ; Valldeoriola F
Parkinsonism Relat Disord; 2022 Jun; 99():33-41. PubMed ID: 35594661
[TBL] [Abstract][Full Text] [Related]
31. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
Yoshida M
Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
[TBL] [Abstract][Full Text] [Related]
32. Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes.
Jiang C; Hopfner F; Berg D; Hu MT; Pilotto A; Borroni B; Davis JJ; Tofaris GK
Mov Disord; 2021 Nov; 36(11):2663-2669. PubMed ID: 33826157
[TBL] [Abstract][Full Text] [Related]
33. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
Sengupta U; Kayed R
Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
[TBL] [Abstract][Full Text] [Related]
34. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
[TBL] [Abstract][Full Text] [Related]
35. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders.
Nilsson J; Constantinescu J; Nellgård B; Jakobsson P; Brum WS; Gobom J; Forsgren L; Dalla K; Constantinescu R; Zetterberg H; Hansson O; Blennow K; Bäckström D; Brinkmalm A
Mov Disord; 2023 Feb; 38(2):267-277. PubMed ID: 36504237
[TBL] [Abstract][Full Text] [Related]
37. Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism.
Yoon WT
Neurol Neurochir Pol; 2018; 52(1):48-53. PubMed ID: 29196058
[TBL] [Abstract][Full Text] [Related]
38. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
39. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J
Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611
[TBL] [Abstract][Full Text] [Related]
40. The Differential Diagnosis and Treatment of Atypical Parkinsonism.
Levin J; Kurz A; Arzberger T; Giese A; Höglinger GU
Dtsch Arztebl Int; 2016 Feb; 113(5):61-9. PubMed ID: 26900156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
